Caricamento...
Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy
Despite recent progress in the development of novel approaches to treat cancer, traditional antineoplastic drugs, such as cisplatin, remain a mainstay of regimens targeting solid tumors. Use of cisplatin is limited by acute kidney injury, which occurs in approximately 30% of patients. Current clinic...
Salvato in:
| Pubblicato in: | Exp Biol Med (Maywood) |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publications
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5813872/ https://ncbi.nlm.nih.gov/pubmed/29231123 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370217745302 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|